Back to Capital Research Global Investors Capital Research Global Investors

BSXBSX
Showing 8 of 21 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in Boston Scientific Corp

Yes. Capital Research Global Investors holds 14,180,571 shares of BSX (Boston Scientific), worth $605.3M, as of its Q2 2026 13F filing. It increased the position by 7,099,684 shares (+100.3%) from Q1 2026. Capital Research Global Investors has held BSX since Q1 2024, across 10 quarterly 13F filings. BSX is 0.1% of Capital Research Global Investors' reported 13F portfolio.

Current Value

$605.3M

Current Shares

14.2M

Total Value Change

+$245.5M

Total Shares Change

+9.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
14.2M
+100.3%
$605.3M0.1%$42.68
51
2026-Q1
Decreased
7.1M
-0.0%
$444.3M0.1%$62.75
0
2025-Q4
Increased
7.1M
+6.8%
$675.5M0.1%$95.35
40
2025-Q3
Increased
6.6M
+0.4%
$647.6M0.1%$97.63
38
2025-Q2
Increased
6.6M
+11.2%
$710M0.1%$107.41
42
2025-Q1
Increased
5.9M
+38.4%
$599.6M0.1%$100.88
50
2024-Q4
Increased
4.3M
+0.0%
$383.7M0.1%$89.32
31
2024-Q3
Increased
4.3M
+30.5%
$359.8M0.1%$83.80
39

Other major holders of BSX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used